Skip to main content
Premium Trial:

Request an Annual Quote

Grace Bio-Labs Inks Deal for Avantra's Path Slides

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Grace Bio-Labs today announced a manufacturing and distribution deal for Avantra Biosciences' Path protein microarray ultra-thin non-porous nitrocellulose slides.

The Path Slides provide many of the benefits of nitrocellulose "in a thin film that allows very low background fluorescence and excellent signal-to-noise ratio," Grace Bio-Labs said in a statement. The Bend, Ore., firm also offers its own Oncyte porous nitrocellulose thin film slides, which it says offers the highest binding capacity for protein applications.

Grace Bio-Labs will sell the Path slides directly from its website and through a distribution agreement with Sigma-Aldrich, which also distributes other Grace Bio-Labs products.

Financial and other terms of the deal were not released.

Grace Bio-Labs develops and manufactures products for protein and cell analysis research.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.